Custom service
Protein Glycosylation Labeling Service
Labelling through the glycans — specific to the Fc, away from the paratope.
Antibodies carry a built-in labelling site that most conjugation chemistry ignores: the N-glycans on the Fc, which sit away from the antigen-binding face. Labelling through those glycans concentrates the modification on the constant region, leaving the paratope untouched — the site-specific result that random lysine labelling cannot guarantee, achieved with chemistry simpler than engineered handles.
Two approaches cover the practical range. Oxidation of glycan vicinal diols with periodate, followed by hydrazide or amine label conjugation, is fast and works on any glycosylated protein. Glycan remodelling — trimming the Fc glycan enzymatically and attaching an azide-tagged sugar, then clicking the label on — is more defined, places a single label per heavy chain and leaves the glycan's effector function less disturbed. The choice is made against the application: detection conjugates tolerate oxidation; therapeutic-adjacent work usually wants remodelling.
Verification distinguishes the approaches from their marketing descriptions. Label count per molecule is measured by intact mass; the antibody's binding activity is measured against the unlabelled parent; and for remodelling, the glycan state is confirmed by LC-MS so the claim of site-specificity is documented rather than asserted.
Glycan labelling suits antibody conjugates where the paratope must stay fully functional — detection antibodies, capture reagents for sandwich assays, therapeutic-conjugate research — and any glycosylated protein with a defined glycan site away from its functional surface.
It is not available for non-glycosylated proteins, and oxidation chemistry is deliberately avoided where the protein's activity depends on other surface glycans that the reaction would also modify.
Each lot is delivered with label count by intact mass, glycan state before and after modification, antigen binding relative to the unlabelled parent, SEC-HPLC and free-label content. For remodelling, the EndoS reaction completeness is documented.
Service Highlights
- Fc-targeted by default. Labels placed on the constant region glycans, away from the antigen-binding face.
- Oxidation route for speed. Periodate oxidation and hydrazide coupling, complete within days for any glycosylated protein.
- Remodelling route for definition. EndoS-mediated trimming plus azide-sugar transfer and click labelling, one defined label per heavy chain.
- Binding preserved. Antigen binding compared with unlabelled parent, since that is the property conjugation is most likely to damage.
- Glycan state documented. LC-MS confirmation of the glycan before and after modification.
- Effector-function awareness. Remodelling strategies that preserve or deliberately modify FcγR binding, stated per project.
How the work runs
Approach selection
Oxidation or remodelling chosen against the application's tolerance for heterogeneity and the glycan's functional role.
Glycan modification
Periodate oxidation or enzymatic trimming and azide-sugar transfer, at optimised reagent levels.
Label conjugation
Hydrazide, oxime or click chemistry couples the label to the modified glycans.
Purification
Free label removed by SEC or affinity; conjugate buffer-exchanged into storage buffer.
Characterisation
Label count by intact mass, glycan state by LC-MS, antigen binding against parent.
Release
Certificate with label count, activity retention, glycan documentation and working dilution.
Specifications & timeline
- Approaches
- Periodate oxidation + hydrazide; EndoS trimming + azide sugar + click
- Labels
- Fluorophores, HRP, AP, biotin, gold, drug payloads
- Label count
- 2–4 per IgG via Fc glycans, measured per lot
- Characterisation
- Intact LC-MS, glycan LC-MS, antigen binding, SEC-HPLC
- Timeline
- 1–3 weeks per conjugate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.